Key result
Higher pre-operative NT-proBNP concentrations independently predicted an increased risk of post-operative acute kidney injury in non-cardiac surgery patients (OR 1.20 per 1-unit ln-increase).
Why the study?
To evaluate the association between pre-operative NT-proBNP and the risk of post-operative acute kidney injury after non-cardiac surgery.
Does the addition of pre-operative NT-proBNP to clinical variables improve the prediction of post-operative acute kidney injury in adult patients undergoing non-cardiac surgery?
Cohort (n=3,949)
No
Does the addition of pre-operative NT-proBNP to clinical variables improve the prediction of post-operative acute kidney injury in adult patients undergoing non-cardiac surgery?
Odds Ratio: 1.2 (95% CI 1.09–1.32)
p-value: p=<0.001
The addition of pre-operative NT-proBNP to conventional clinical risk models modestly improves the prediction of post-operative acute kidney injury in patients undergoing non-cardiac surgery.
NT-proBNP may flag PO-AKI risk after non-cardiac surgery; leaves open whether measurement improves outcomes or should guide care.
Objective To evaluate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of post-operative acute kidney injury (PO-AKI). Methods The electronic medical records and laboratory results were obtained from 3,949 adult patients (≥18 years) undergoing non-cardiac surgery performed between 1 October 2012 to 1 October 2019 at the Third Xiangya Hospital, Central South University, China. Collected data were analyzed retrospectively. Results In all, 5.3% (209 of 3,949) of patients developed PO-AKI. Pre-operative NT-proBNP was an independent predictor of PO-AKI. After adjustment for significant variables, OR for AKI of highest and lowest NT-proBNP quintiles was 1.96 (95% CI, 1.04–3.68, P = 0.008), OR per 1-unit increment in natural log transformed NT-proBNP was 1.20 (95% CI, 1.09–1.32, P < 0.001). Compared with clinical variables alone, the addition of NT-proBNP modestly improved the discrimination [change in area under the curve(AUC) from 0.82 to 0.83, ΔAUC=0.01, P = 0.024] and the reclassification (continuous net reclassification improvement 0.15, 95% CI, 0.01–0.29, P = 0.034, improved integrated discrimination 0.01, 95% CI, 0.002–0.02, P = 0.017) of AKI and non-AKI cases. Conclusions Results from our retrospective cohort study showed that the addition of pre-operative NT-proBNP concentrations could better predict post-operative AKI in a cohort of non-cardiac surgery patients and achieve higher net benefit in decision curve analysis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted a cohort in Post-operative acute kidney injury (PO-AKI) (n=3,949). Pre-operative N-terminal pro-B-type natriuretic peptide (NT-proBNP) vs. Lower NT-proBNP levels was evaluated on Post-operative acute kidney injury (PO-AKI) within 7 days (OR 1.20, 95% CI 1.09-1.32, p=<0.001). Higher pre-operative NT-proBNP concentrations independently predicted an increased risk of post-operative acute kidney injury in non-cardiac surgery patients (OR 1.20 per 1-unit ln-increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: